Dinkel, H., Stelmach, R., Zschaebitz, S., Haack, M., Aydogdu, C., Casuscelli, J., Egenolf, T., Silberg, M., Steinestel, J., Strauss, A., Kirchhoff, F., Ahrens, M., Cathomas, R., Özdemir, B. C., Gossler, C., Ivanyi, P., Rehlinghaus, M., Hilser, T., Grünwald, V., Schlack, K. (2026). Second-line therapy after ipilimumab and nivolumab in advanced renal cell carcinoma: A multicenter real-world study (GUARDIANS).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.437